Chronic use of proton pump inhibitors: Is the risk of osteoporosis and fractures real?

被引：1
|
作者：
Marti-Cabrera, Miguel [1 ,2 ]
Marti-Masanet, Miguel [1 ]
Esplugues, Juan V. [1 ,2 ,3 ]
机构：
[1] Univ Valencia, Dept Farmacol, Fac Med & Odontol, E-46003 Valencia, Spain
[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Valencia, Spain
[3] Hosp Univ Dr Peset Aleixandre, Valencia, Spain
来源：
GASTROENTEROLOGIA Y HEPATOLOGIA | 2011年 / 34卷 / 04期
关键词：
PPI; calcium; toxicity; fractures; osteoporosis; inhibition of acid secretion; GASTRIC-ACID SECRETION; BONE-MINERAL DENSITY; L-LACTIC ACID; HIP FRACTURE; CALCIUM-ABSORPTION; RESORPTION; PHOSPHATE; OMEPRAZOLE; SAFETY; WOMEN;
D O I：
10.1016/j.gastrohep.2011.01.002
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Proton pump inhibitors (PPI) are one of the most widely used groups of drugs and their potential toxicity is periodically reviewed, emphasizing aspects originally considered secondary. The present review analyzes the physiological and pharmacological bases and the scarce clinical evidence for a potential association between the continued administration of PPI and the development of osteoporosis and bone fractures. Both disorders are clearly related to calcium homeostasis and are highly important in elderly patients due to their poor general prognosis and disabling consequences. (C) 2010 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码：271 / 277
页数：7
相关论文
共 50 条
  • [1] Use of Proton Pump Inhibitors and Risk of Osteoporosis-Related Fractures
    Mikosch, Peter
    JOURNAL FUR MINERALSTOFFWECHSEL, 2009, 16 (01): : 37 - 38
  • [2] Use of proton pump inhibitors and risk of osteoporosisrelated fractures
    Targownik, Laura E.
    Lix, Lisa M.
    Metge, Colleen J.
    Prior, Heather J.
    Leung, Stella
    Leslie, William D.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2008, 179 (04) : 319 - 326
  • [3] Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures
    Fournier, Marc R.
    Targownik, Laura E.
    Leslie, William D.
    MATURITAS, 2009, 64 (01) : 9 - 13
  • [4] Proton Pump Inhibitors and Risk of Osteoporosis
    Gasser, Rudolf W.
    JOURNAL FUR MINERALSTOFFWECHSEL & MUSKULOSKELETTALE ERKRANKUNGEN, 2020, 27 (01): : 2 - 7
  • [5] CONSTANT STOMACHS, CONCERNED BONES: CHRONIC USE OF PROTON PUMP INHIBITORS AND RISK OF FRACTURES
    Sanchez, Ariel
    REVISTA MEDICA DE ROSARIO, 2009, 75 (01): : 6 - 8
  • [6] PROTON PUMP INHIBITORS AND RISK OF FRACTURES
    Sanchez, Ariel
    REVISTA MEDICA DE ROSARIO, 2019, 85 (01): : 35 - 35
  • [7] Proton pump inhibitors and osteoporosis-related fractures
    Targownik, Laura E.
    Leslie, William D.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 180 (06) : 643 - 643
  • [8] PROTON PUMP INHIBITORS: A RISK FACTOR FOR OSTEOPOROSIS?
    Criveanu, C.
    Ciurea, P. L.
    Vreju, A. F.
    Musetescu, A. E.
    Barbulescu, A.
    Dinescu, S. C.
    Firulescu, C. S.
    Predescu, O. R.
    Rosu, A.
    Palici, C. F.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S719 - S719
  • [9] Chronic Proton Pump Inhibitor Use Is Not Associated with An Increased Risk of Osteoporosis
    Targownik, Laura E.
    Lix, Lisa M.
    Leung, Stella
    Leslie, William D.
    GASTROENTEROLOGY, 2009, 136 (05) : A70 - A70
  • [10] Proton Pump Inhibitors and Risk of Bone Fractures
    Grigorios I. Leontiadis
    Paul Moayyedi
    Current Treatment Options in Gastroenterology, 2014, 12 (4) : 414 - 423
12345